SP166THE NATURAL COURSE OF IgA NEPHROPATHY PRESENTING WITH ISOLATED HEMATURIA AT THE TIME OF DIAGNOSIS
Ji Won Min, Seok Joon Shin, Euy Jin Choi, Ho Cheol Song
Abstract
Open-access reader
Ji Won Min, Seok Joon Shin, Euy Jin Choi, Ho Cheol Song
Abstract
Open-access reader
INTRODUCTION AND AIMS: The outcome of patients with IgA nephropathy who present with isolated microscopic hematuria at the time of diagnosis is not well studied. METHODS: We investigated the long-term prognosis of 162 patients with biopsy-proven IgA nephropathy, who presented with isolated microscopic hematuria, preserved renal function (estimated glomerular filtration rate (eGFR) ≥60ml/min/1.73m2), and minimal or no proteinuria (spot urine protein/creatinine ratio ≤0.2). RESULTS: Baseline characteristics were as follows. Mean age (SD) at the time of diagnosis was 37.9 (12.5) years, median eGFR (interquartile range) at the time of diagnosis was 97.3 (88.1-110.8) ml/min/1.73m2, and proteinuria level 0.08 (0.06-0.12). After a median follow-up period of 107 months, eGFR was 87.7 (77.9-101.9) ml/min/1.73 m2 and proteinuria 0.07 (0.05-0.11). No patients progressed to advanced chronic kidney disease (eGFR below 30 ml/min/1.73 m2). Significant proteinuria (spot urine P/C ratio >0.2) developed in 20 (12.3%) patients, and median proteinuria level in this group was 0.82 (0.33-1.36). When the group of patients who developed significant proteinuria was compared to the group of patients who did not, we found that follow-up median eGFR was significantly lower in the group with proteinuria compared to the group without proteinuria (79.1[69.4-99.1] vs. 89.3[78.9-102.1], P=0.021). There was no difference of baseline characteristics (underlying diabetes, hypertension, sex, age, baseline eGFR, and use of anti-hypertensive medication) between the 2 groups. On histopathological findings using the semiquantative classification, there was no significant difference of the median activity index score (total 10) and chronicity index score (total 12) between the 2 groups. CONCLUSIONS: Our study is one of the largest single-center studies to date on the prognosis of this cohort. As reported before, the long-term prognosis of IgA nephropathy patients with isolated hematuria at the time of diagnosis is excellent.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
INTRODUCTION AND AIMS: The outcome of patients with IgA nephropathy who present with isolated microscopic hematuria at the time of diagnosis is not well studied. METHODS: We investigated the long-term prognosis of 162 patients with biopsy-proven IgA nephropathy, who presented with isolated microscopic hematuria, preserved renal function (estimated glomerular filtration rate (eGFR) ≥60ml/min/1.73m2), and minimal or no proteinuria (spot urine protein/creatinine ratio ≤0.2). RESULTS: Baseline characteristics were as follows. Mean age (SD) at the time of diagnosis was 37.9 (12.5) years, median eGFR (interquartile range) at the time of diagnosis was 97.3 (88.1-110.8) ml/min/1.73m2, and proteinuria level 0.08 (0.06-0.12). After a median follow-up period of 107 months, eGFR was 87.7 (77.9-101.9) ml/min/1.73 m2 and proteinuria 0.07 (0.05-0.11). No patients progressed to advanced chronic kidney disease (eGFR below 30 ml/min/1.73 m2). Significant proteinuria (spot urine P/C ratio >0.2) developed in 20 (12.3%) patients, and median proteinuria level in this group was 0.82 (0.33-1.36). When the group of patients who developed significant proteinuria was compared to the group of patients who did not, we found that follow-up median eGFR was significantly lower in the group with proteinuria compared to the group without proteinuria (79.1[69.4-99.1] vs. 89.3[78.9-102.1], P=0.021). There was no difference of baseline characteristics (underlying diabetes, hypertension, sex, age, baseline eGFR, and use of anti-hypertensive medication) between the 2 groups. On histopathological findings using the semiquantative classification, there was no significant difference of the median activity index score (total 10) and chronicity index score (total 12) between the 2 groups. CONCLUSIONS: Our study is one of the largest single-center studies to date on the prognosis of this cohort. As reported before, the long-term prognosis of IgA nephropathy patients with isolated hematuria at the time of diagnosis is excellent.
Key concepts: Medicine, Nephropathy, Glomerulonephritis, Immunology, Dermatology, Kidney, Internal medicine, Endocrinology